1 Pharmacogenomics (PGx) Market Overview
1.1 Product Overview and Scope of Pharmacogenomics (PGx)
1.2 Classification of Pharmacogenomics (PGx) by Type
1.2.1 Global Pharmacogenomics (PGx) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarray
1.2.5 Sequencing
1.2.6 Other
1.3 Global Pharmacogenomics (PGx) Market by Application
1.3.1 Overview: Global Pharmacogenomics (PGx) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Global Pharmacogenomics (PGx) Market by Regions
1.4.1 Global Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pharmacogenomics (PGx) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Myriad Genetics, Inc.
2.2.1 Myriad Genetics, Inc. Details
2.2.2 Myriad Genetics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Myriad Genetics, Inc. SWOT Analysis
2.2.4 Myriad Genetics, Inc. Product and Services
2.2.5 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astrazeneca
2.3.1 Astrazeneca Details
2.3.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astrazeneca SWOT Analysis
2.3.4 Astrazeneca Product and Services
2.3.5 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affymetrix, Inc.
2.4.1 Affymetrix, Inc. Details
2.4.2 Affymetrix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affymetrix, Inc. SWOT Analysis
2.4.4 Affymetrix, Inc. Product and Services
2.4.5 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratory Corporation of America Holdings SWOT Analysis
2.5.4 Laboratory Corporation of America Holdings Product and Services
2.5.5 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Assurex Health, Inc
2.6.1 Assurex Health, Inc Details
2.6.2 Assurex Health, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Assurex Health, Inc SWOT Analysis
2.6.4 Assurex Health, Inc Product and Services
2.6.5 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer, Inc
2.7.1 Pfizer, Inc Details
2.7.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer, Inc SWOT Analysis
2.7.4 Pfizer, Inc Product and Services
2.7.5 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Illumina, Inc.
2.8.1 Illumina, Inc. Details
2.8.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Illumina, Inc. SWOT Analysis
2.8.4 Illumina, Inc. Product and Services
2.8.5 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.9 GeneDX
2.9.1 GeneDX Details
2.9.2 GeneDX Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GeneDX SWOT Analysis
2.9.4 GeneDX Product and Services
2.9.5 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pathway Genomics
2.10.1 Pathway Genomics Details
2.10.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pathway Genomics SWOT Analysis
2.10.4 Pathway Genomics Product and Services
2.10.5 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Transgenomic, Inc.
2.11.1 Transgenomic, Inc. Details
2.11.2 Transgenomic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Transgenomic, Inc. SWOT Analysis
2.11.4 Transgenomic, Inc. Product and Services
2.11.5 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Qiagen, Inc.
2.12.1 Qiagen, Inc. Details
2.12.2 Qiagen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Qiagen, Inc. SWOT Analysis
2.12.4 Qiagen, Inc. Product and Services
2.12.5 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Thermo Fisher Scientific SWOT Analysis
2.13.4 Thermo Fisher Scientific Product and Services
2.13.5 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.14 Rocheg
2.14.1 Rocheg Details
2.14.2 Rocheg Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Rocheg SWOT Analysis
2.14.4 Rocheg Product and Services
2.14.5 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.15 Teva Pharmaceutical Industries Ltd.
2.15.1 Teva Pharmaceutical Industries Ltd. Details
2.15.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.15.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.15.5 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmacogenomics (PGx) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacogenomics (PGx) Players Market Share
3.2.2 Top 10 Pharmacogenomics (PGx) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Regions
4.2 North America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.3 Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.5 South America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5 North America Pharmacogenomics (PGx) Revenue by Countries
5.1 North America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
5.2 USA Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.3 Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.4 Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6 Europe Pharmacogenomics (PGx) Revenue by Countries
6.1 Europe Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
6.2 Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.3 UK Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.4 France Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.5 Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.6 Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries
7.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
7.2 China Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.3 Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.4 Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.5 India Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8 South America Pharmacogenomics (PGx) Revenue by Countries
8.1 South America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
8.2 Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8.3 Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pharmacogenomics (PGx) by Countries
9.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.3 UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.4 Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.5 South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Type (2015-2020)
10.2 Global Pharmacogenomics (PGx) Market Forecast by Type (2019-2024)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.4 Microarray Revenue Growth Rate (2015-2025)
10.5 Sequencing Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Pharmacogenomics (PGx) Market Segment by Application
11.1 Global Pharmacogenomics (PGx) Revenue Market Share by Application (2015-2020)
11.2 Pharmacogenomics (PGx) Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases (CVD) Revenue Growth (2015-2020)
11.4 Central Nervous System (CNS) Revenue Growth (2015-2020)
11.5 Cancer/Oncology Revenue Growth (2015-2020)
11.6 Infectious Diseases Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.1 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.2 Global Pharmacogenomics (PGx) Market Forecast by Regions (2021-2025)
12.3 North America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.4 Europe Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.6 South America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
【免責事項】
https://www.globalresearch.jp/disclaimer